Guide Clinical Decision Making with Molecular Diagnostics

An educational resource page

Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.

Emerging Trends in Respiratory Infectious Diseases

Given the significant disease burden of upper RTIs, it is critical to stay aware of emerging trends regarding respiratory infections. Understanding these global trends is vital for the early detection of outbreaks and can help guide public health responses and campaigns. 

Revolutionize patient care through clinically relevant molecular testing 

 

Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices. 

 

While traditional methods continue to have an important role in diagnosis of infectious diseases and other applications, qPCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.

 

Explore the resources below to learn more about the role molecular testing can serve in patient care and management decisions.


Educational resources by applications and focus areas

Respiratory tract infections

Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.

Gastrointestinal tract infections

There are challenges in diagnosing infectious gastroenteritis. Molecular testing can enable laboratories to address those challenges.

Urinary tract infections

Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this molecular testing method. 

Sexually transmitted and vaginal infections

Early and accurate detection and differentiation is the first step toward understanding the cause of infection and determining next steps.

Viral hepatitis molecular testing

Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load.

HIV molecular testing

Explore how molecular genomic and genetic testing serve as powerful tools in the global fight to end HIV.

Pharmacogenomics

The future of health care includes factoring PGx genetic test results into decision making.

Implementing diagnostic tests

Simplify diagnostic test implementation in clinical labs.

Antibiotic resistance

Next Step for Molecular Diagnostics and Antimicrobial Resistance: How to Maximize Advanced Technology in the Lab.

Clinically relevant content

Hear from industry leaders as they discuss strategies for designing molecular panels that are both clinically relevant and payor-supported.

Driving productivity

The CEO of Wise Diagnostic Systems shares insights on practical considerations when shifting from traditional methods to molecular technologies.

Diagnostics—Fulfilling its potential

A three-part educational series hosted in collaboration with Arizona State University.


eBooks and learning guides

eBook: Industry leader interviews in infectious diseases and pharmacogenomics

Designed to educate and inform about the role molecular testing can serve in patient management and its potential impact on global health care decisions.

eBook: The value of molecular testing

Collected interviews with medical experts, intended to aid lab professionals and clinicians to better understand the clinical value of molecular testing. 

Respiratory Tract Infections Learning Guide

This comprehensive review of viral, bacterial, fungal, and parasitic RTIs is divided into four chapters.

HIV Learning Guide: A Primer for Healthcare Professionals

This comprehensive learning guide contains case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.


Blogs, articles, and whitepapers

Integrating PGx into the standard of care

A white paper about PGx implementation and tools that are readily available.

STIs: Convention vs. Convenience

A white paper comparing clinician-collected or at-home collected samples for testing for STIs.

Transplant-associated infections management

A white paper showcasing the role of PCR-based molecular testing.

Clinical Conversations

Molecular testing content for clinical lab professionals and clinicians.